Evidence map›Paper›PMID 39041608›Full record

ArticleCancer reports (Hoboken, N.J.)2024

Pan-Cancer Analysis Links Altered RNA m

Anni Su, Renhua Song, Justin J-L Wong

Abstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Overexpression of mThe Journal of pathology · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anni SuEpigenetics and RNA Biology Laboratory, Charles Perkins Centre, University of Sydney, Camperdown, Australia.
Renhua SongEpigenetics and RNA Biology Laboratory, Charles Perkins Centre, University of Sydney, Camperdown, Australia.
Justin J-L WongEpigenetics and RNA Biology Laboratory, Charles Perkins Centre, University of Sydney, Camperdown, Australia.ORCID 0000-0002-7038-5079

Funding

Australian Research Council DP230102041National Health and Medical Research Council 2010647NSW Health 46014
6 · The paper itself

Abstract

backgroundN7-methylguanosine (m

aimsThis study aims to systematically investigate the molecular alteration and clinical relevance of m

methodsWe analysed genome, transcriptome and clinical data from the Cancer Genome Atlas Research Network spanning 33 types of human cancers for aberrant changes in genes encoding m

resultWe demonstrate that m

conclusionOur analyses indicate the genetic alterations, expression patterns and clinical relevance of m

Indexed as

Gene Expression Regulation, NeoplasticNeoplasmsBiomarkers, TumorGuanosineHumansImmunotherapyMethyltransferasesPrognosisTranscriptome7-methylguanosineBiomarkers, TumorGuanosineMethyltransferases

Identifiers

PMID39041608
PMCPMC11264101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.